Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
PZ Cussons is under pressure to justify Nigerian deal as results loom

Full-year results to be published on 26 September from consumer goods firm PZ Cussons (PZC) come hot on the heels of the company’s announcement that it plans to take full control of its Nigerian business.
This decision may come under some scrutiny as the impact of the devaluation of the Nigerian naira could well mar the upcoming numbers. Volatility in the currency and the country itself has been a regular source of profit warnings from the business.
Shore Capital analyst Darren Shirley says the proposed acquisition makes strategic and financial sense, yet the price paid raised some eyebrows.
The company has offered £23 million in cash to acquire the 26.7% of PZ Cussons Nigeria it doesn’t already own, representing a 20% premium to the undisturbed price.
The Manchester-headquartered firm insisted the acquisition will ‘significantly simplify and strengthen’ its business in Nigeria, which has seen an improvement in profitability in recent years, putting in place ‘a sustainable structure and platform to maximise long-term growth and value’.
Investor focus when the full-year results are published is also likely to fall on how PZ Cussons is balancing price and volume across a portfolio of brands which include Carex, Cussons Baby, Imperial Leather and Original Source. This is a conundrum facing much of its peer group, which in passing on higher costs to consumers have created an incentive to trade down to unbranded alternatives.
UK UPDATES OVER THE NEXT 7 DAYS
FULL-YEAR RESULTS
September 22: Stranger Holdings
September 25: Wilmington
September 26: Close Brothers, Finsbury Food, Newmark Security, Origin Enterprises, PZ Cussons, Time Finance
September 27: Avingtrans
September 28: Hansard Global
HALF-YEAR RESULTS
September 22: First Tin
September 25: Alphawave IP, Aurrigo International, IQGEO, Ondine Biomedical, Venture Life
September 26: Alliance Pharma, Animalcare, Cambridge Cognition, Card Factory, Diaceutics, DigitalBox, EKF Diagnostics, Ergomed, Lifesafe, The Mission, Mortgage Advice Bureau, Next 15, Niox, Tinybuild, Yu Group
September 27: Amicorp, Arix Bioscience, Biome Technologies, BioPharma Credit, Everyman Media, Pantheon Infrastructure, Pendragon, Pennant International, Plant Health Care, Safestyle, Skillcast, Xeros Technology
September 28: Avacta, Ceres Power, Novacyt, Phoenix, RBG, Shield Therapeutics, Trellus, Trinity Exploration & Production, XLMedia
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
Issue contents
Feature
Great Ideas
Investment Trusts
News
- TSMC spooks chip industry with slowdown threat
- Centrica share price rally has been ‘meteoric’, up 420% since 2020
- Frasers could be the key to Shein becoming a bigger player in the UK
- Drax shares tank on fears over new report on UK Government biomass strategy
- Bakkavor shares remain in the doldrums after workers vote to strike